These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8275659)

  • 1. [Tauro-ursodeoxycholic acid vs. ursodeoxycholic acid in the dissolution of biliary calculi. Results of a single blind study].
    Gallo V; De Micheli AG; Chiandussi L
    Clin Ter; 1993 Nov; 143(5):421-8. PubMed ID: 8275659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Taurodeoxycholic acid in the treatment of primary biliary cirrhosis. A controlled study in comparison to ursodeoxycholic acid].
    Ferri F; Bernocchi P; Fedeli S
    Clin Ter; 1993 Oct; 143(4):321-6. PubMed ID: 8258267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
    Venneman NG; Besselink MG; Keulemans YC; Vanberge-Henegouwen GP; Boermeester MA; Broeders IA; Go PM; van Erpecum KJ
    Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
    Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
    Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrence of vesicular microlithiasis. Controlled study with different dosis of ursodeoxycholic acid].
    Guma C; Viola L; Thomé M; Galdame O; Facelli A; Di Bucci A; Vaimberg D
    Medicina (B Aires); 1998; 58(5 Pt 1):474-6. PubMed ID: 9922479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tauroursodeoxycholic acid (TUDCA) on biliary lipid composition.
    Muraca M; Vilei MT; Cianci V; Liu XT
    Ital J Gastroenterol; 1995; 27(8):439-40. PubMed ID: 8775471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rationale for the use of bile salts after cholecystectomy: results of a controlled clinical study using tauroursodeoxycholic acid (TUDCA)].
    Croce E; Golia M; Trignano M; Occhioni G; Pisano J; La Rocca R; Capomagi A; De Sanctis A; Morino M; Fornari M
    Ann Ital Chir; 1993; 64(5):533-7. PubMed ID: 8010582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bile acid therapy vs. placebo before and after extracorporeal shock wave lithotripsy of gallbladder stones].
    Ugeskr Laeger; 1998 Jun; 160(23):3408-12. PubMed ID: 9627510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis.
    Ma H; Zeng M; Han Y; Yan H; Tang H; Sheng J; Hu H; Cheng L; Xie Q; Zhu Y; Chen G; Gao Z; Xie W; Wang J; Wu S; Wang G; Miao X; Fu X; Duan L; Xu J; Wei L; Shi G; Chen C; Chen M; Ning Q; Yao C; Jia J
    Medicine (Baltimore); 2016 Nov; 95(47):e5391. PubMed ID: 27893675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy.
    Saraswat VA; Sharma BC; Agarwal DK; Kumar R; Negi TS; Tandon RK
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1206-11. PubMed ID: 15377301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
    Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of dyspeptic disorders, lithiasis and biliary dyskinesia with ursodeoxycholic acid. Analysis of a controlled multicenter study].
    Realini S; Reiner M; Frigerio G
    Schweiz Med Wochenschr; 1980 May; 110(22):879-80. PubMed ID: 6996086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal shock wave lithotripsy of gallstones with oral dissolution. Results in course of ten years in Czech Republic in correlation to indication criteria.
    Benes J; Chmel J; Blazek O; Marecek Z
    Sb Lek; 2001; 102(1):17-22. PubMed ID: 11830914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects.
    Leuschner U; Guldutuna S; Bhatti S; Elze A; Imhof M; You T; Zimmer G
    Ital J Gastroenterol; 1995 Sep; 27(7):376-7. PubMed ID: 8563010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
    Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
    Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary experience with the use of ursodeoxycholic acid in the treatment of biliary calculosis].
    Bonfiglio M; Casamichiela M; Garagnani A
    Clin Ter; 1979 Mar; 88(5):491-7. PubMed ID: 466971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.